Chargement en cours...
Pharmacologic inhibition of PI3K p110δ in mutant Shp2E76K-expressing mice
Juvenile myelomonocytic leukemia is a childhood malignancy that lacks effective chemotherapies and thus has poor patient outcomes. PI3K p110δ has been found to promote hyperproliferation of cells expressing mutant Shp2. In this study, we tested the efficacy of a PI3Kδ inhibitor in mice expressing th...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5689572/ https://ncbi.nlm.nih.gov/pubmed/29156682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21455 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|